2m 2m 2m 2m 2m 2m 2m
AKTIS ONCOLOGY (AKTS)
NASDAQ
$16.75+$0.32 (+1.98%)
Price as of Oct 22, 2026 7:30 PM EDT- $882.5MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
AKTIS ONCOLOGY (AKTS)
$16.75+$0.32 (+1.98%)
AKTS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.42 | ||
Change | +$0.34 (+2.11%) | ||
Open | $16.09 | ||
High | $16.64 | ||
Low | $15.98 | ||
Previous Close | $16.08 | ||
Volume | 390,680 | ||
30-Day Average Volume | 385,052 | ||
1-Week Change | -0.42% | ||
1-Month Change | -23.38% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 53.7M | ||
Total Assets | $557.6M | ||
Market Cap | $882.5M | ||
Enterprise Value | $800.0M | ||
Period: QTR TTM FY | |||
Revenue | $3.4M | ||
Net Income | -$24.1M | ||
Free Cash Flow | -$21.8M | ||
EBIT | -$24.1M | ||
EBITDA | -$23.3M | ||
Net Working Capital | $492.4M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | 236 | ||
P/B | 2 | ||
P/E | -37 | ||
PEG | 2 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1.094891 : 1 | ||
Last Split Date | 04/24/2015 | ||